The top five financial truths in blockbuster Amgen-Onyx deal
For sheer size and scale, Amgen’s $10.4 billion purchase of South San Francisco-based cancer drug maker Onyx Pharmaceuticals dwarfs any recent deal in the Tri-Counties. For size, let’s remember that Dole Food Co. is selling its entire self for about $1.3 billion and that Santa Barbara Bank & Trust parent Pacific Capital Bancorp, previously the Read More →
Read More →Who will lead the tri-county corporate scene over the next decade?
The ranks of corporate leadership in the Tri-Counties are undergoing a bit of a shakeup.
Read More →Guest op/ed: Navigate these hurdles to ride the M&A wave
By John F. Stuart, Kenneth E. Moore and Ryan J. Barncastle on September 16, 2011 The marketplace is rich with discussion concerning the future of mergers and acquisitions. With so much talk about the coming wave of acquisitions, what is preventing more deals from being announced? The answer to that question requires us to revisit Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
